Whales with a lot of money to spend have taken a noticeably bullish stance on Merck & Co.
Looking at options history for Merck & Co MRK we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 25% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $157,700 and 6, calls, for a total amount of $517,740.
Predicted Price Range
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $120.0 to $130.0 for Merck & Co over the recent three months.
Analyzing Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Merck & Co's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Merck & Co's significant trades, within a strike price range of $120.0 to $130.0, over the past month.
Merck & Co Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | CALL | TRADE | BULLISH | 01/17/25 | $15.45 | $15.45 | $15.45 | $120.00 | $309.0K | 2.4K | 12 |
| MRK | PUT | SWEEP | BULLISH | 01/16/26 | $7.35 | $7.1 | $7.1 | $120.00 | $85.2K | 1.5K | 205 |
| MRK | PUT | SWEEP | BEARISH | 06/14/24 | $0.62 | $0.53 | $0.58 | $129.00 | $72.5K | 188 | 9 |
| MRK | CALL | TRADE | BULLISH | 01/17/25 | $9.3 | $9.05 | $9.2 | $130.00 | $70.8K | 3.6K | 83 |
| MRK | CALL | SWEEP | BULLISH | 06/07/24 | $5.35 | $5.2 | $5.31 | $126.00 | $52.9K | 1.9K | 203 |
About Merck & Co
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Following our analysis of the options activities associated with Merck & Co, we pivot to a closer look at the company's own performance.
Current Position of Merck & Co
- With a volume of 2,563,727, the price of MRK is up 0.09% at $130.64.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 53 days.
Expert Opinions on Merck & Co
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $155.0.
- An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $155.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Merck & Co options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
